Lv4
498 积分 2023-08-17 加入
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy
23小时前
待确认
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
3天前
已完结
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
4天前
已完结
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
4天前
已关闭
B Cell Development and Maturation
5天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
9天前
已完结
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
9天前
已完结
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
9天前
已关闭
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas
9天前
已关闭
HIV immune evasin Nef enhances allogeneic CAR T cell potency
12天前
已完结
皖公网安备34019202002308
